The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Bindarit     2-[(1-benzylindazol-3- yl)methoxy]-2-methyl...

Synonyms: SureCN187885, AG-K-02376, CHEMBL2107549, ACMC-20agak, ANW-72042, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Bindarit

  • Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease [1].
  • Survival was even more prolonged when bindarit (0.5% medicated diet) was combined with a low dose of methylprednisolone (1.5 mg/kg i.p.), which that only partially modifies proteinuria and survival of lupus mice, in an additional group of animals (N = 16) [1].
  • As an alternative to classical immunosuppressants in experimental lupus nephritis, we looked at bindarit, 2-methyl-2-[[1-phenylmethyl)-1H-indazol-3-y1]methoxy]propanoic acid, a novel molecule devoid of immunosuppressive effects, which selectively reduces chronic inflammation in rat adjuvant arthritis [1].
  • The present study aimed to define the role of MCP-1 in acute pancreatitis with the use of bindarit [2].
  • OBJECTIVE: The present study was designed to investigate the effects of bindarit on animal survival and renal damage in murine lupus autoimmune disease [3].
  • Our data support the use of inhibitors of MCP production in the treatment of arthritogenic alphavirus syndromes and suggest that bindarit may be useful in treating RRVD and other alphavirus-induced arthritides in humans [4].
 

High impact information on Bindarit

  • Bindarit completely prevented MCP-1 up-regulation [1].
  • In a model of acute pancreatitis induced by caerulein hyperstimulation, prophylactic as well as therapeutic treatment with bindarit significantly reduced MCP-1 levels in the pancreas [2].
  • 2-Methyl-2-[[1-(phenylmethyl)-1H-indazol-3yl]methoxy]propanoic acid (bindarit) has been shown to preferentially inhibit MCP-1 production in vitro in monocytes and in vivo without affecting the production of the cytokines IL-1, IL-6, or the chemokines IL-8, protein macrophage inflammatory-1alpha, and RANTES [2].
  • Abnormal glycosylation of hemopexin in arthritic rats can be blocked by bindarit [5].
  • The involvement of protein denaturation in the production of new antigenic determinants, their pathogenic relevance in the development of adjuvant arthritis and the possibility that protein stabilization by bindarit could be the mechanism of action of the drug are discussed [6].
 

Chemical compound and disease context of Bindarit

 

Anatomical context of Bindarit

 

Associations of Bindarit with other chemical compounds

 

Gene context of Bindarit

  • The results presented here show that bindarit is a preferential inhibitor of the production of MCP-1 in vitro and in vivo and suggest that its beneficial effects in models of joint and kidney inflammation are related to its anti-MCP-1 action [9].
  • Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production [7].
  • Bindarit (2-methyl-2-[[1-(phenylmethyl)-1H-indazol-3yl]methoxy]propan oic acid) dose-dependently inhibited MCP-1 and TNF-alpha production induced in vitro in monocytes by LPS and Candida albicans [9].

References

  1. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. Zoja, C., Corna, D., Benedetti, G., Morigi, M., Donadelli, R., Guglielmotti, A., Pinza, M., Bertani, T., Remuzzi, G. Kidney Int. (1998) [Pubmed]
  2. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Bhatia, M., Ramnath, R.D., Chevali, L., Guglielmotti, A. Am. J. Physiol. Gastrointest. Liver Physiol. (2005) [Pubmed]
  3. Bindarit prolongs survival and reduces renal damage in NZB/W lupus mice. Guglielmotti, A., Aquilini, L., D'Onofrio, E., Rosignoli, M.T., Milanese, C., Pinza, M. Clinical and experimental rheumatology. (1998) [Pubmed]
  4. Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Rulli, N.E., Guglielmotti, A., Mangano, G., Rolph, M.S., Apicella, C., Zaid, A., Suhrbier, A., Mahalingam, S. Arthritis Rheum. (2009) [Pubmed]
  5. Abnormal glycosylation of hemopexin in arthritic rats can be blocked by bindarit. Saso, L., Silvestrini, B., Zwain, I., Guglielmotti, A., Luparini, M.R., Cioli, V., Cheng, C.Y. J. Rheumatol. (1992) [Pubmed]
  6. A new protein antidenaturant agent, bindarit, reduces secondary phase of adjuvant arthritis in rats. Cioli, V., Ciarniello, M.G., Guglielmotti, A., Luparini, M.R., Durando, L., Martinelli, B., Catanese, B., Fava, L., Silvestrini, B. J. Rheumatol. (1992) [Pubmed]
  7. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production. Guglielmotti, A., D'Onofrio, E., Coletta, I., Aquilini, L., Milanese, C., Pinza, M. Inflamm. Res. (2002) [Pubmed]
  8. Chronic inflammatory response in the rat can be blocked by bindarit. Guglielmotti, A., Silvestrini, B., Saso, L., Zwain, I., Cheng, C.Y. Biochem. Mol. Biol. Int. (1993) [Pubmed]
  9. A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Sironi, M., Guglielmotti, A., Polentarutti, N., Fioretti, F., Milanese, C., Romano, M., Vigini, C., Coletta, I., Sozzani, S., Bernasconi, S., Vecchi, A., Pinza, M., Mantovani, A. Eur. Cytokine Netw. (1999) [Pubmed]
 
WikiGenes - Universities